Jove
Visualize
Contact Us

Related Experiment Videos

[Immunosuppressive guidelines. The differences and advantages]

J M Arizón del Prado1

  • 1Servicio de Cardiología, Hospital Reina Sofía, Córdoba.

Revista Espanola De Cardiologia
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The falling incidence of hematologic cancer after heart transplantation.

Clinical transplantation·2014
Same author

Influence of steroid dosage, withdrawal, and reinstatement on survival after heart transplantation: results from the RESTCO study.

Transplantation proceedings·2012
Same author

Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Oral anticoagulation in patients aged 75 years or older with chronic non-valvar atrial fibrillation: effectiveness and safety in daily clinical practice.

Heart (British Cardiac Society)·2005
Same author

[Tacrolimus blood levels and incidence of graft rejection in heart transplantation].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2005
Same author

Detection of transplant heart rejection by analysis of endomyocardial voltage.

Transplantation proceedings·2003
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

The field of transplantation is undergoing a revolution in immunosuppressive drug development. Research focuses on novel pharmacological and non-pharmacological approaches to improve patient outcomes and manage transplant rejection.

Area of Science:

  • Immunology
  • Transplantation Science
  • Pharmacology

Background:

  • Current immunosuppressive regimens for transplantation are evolving rapidly.
  • Understanding the immunology and pathophysiology of transplant rejection is crucial for developing new therapies.

Purpose of the Study:

  • To investigate novel immunosuppressive drugs and alternative non-pharmacological methods in transplantation.
  • To identify improved strategies for managing severe and repetitive transplant rejection.

Main Methods:

  • Exploration of new immunosuppressive drugs through experimental and clinical protocols.
  • Study of non-pharmacological methods for rejection control.
  • Investigation of chimerism and xenotransplantation.

Related Experiment Videos

Main Results:

  • The investigation aims to discover superior immunosuppressive drugs.
  • Alternative methods are being explored for managing difficult rejection cases.
  • Research encompasses chimerism and xenotransplantation studies.

Conclusions:

  • Advancements in immunology and physiopathology knowledge are driving innovation in immunosuppression.
  • The development of better immunosuppressive strategies is essential for successful transplantation.
  • Research into chimerism and xenotransplantation offers future possibilities.